Novartis drug Afinitor® extends progression-free survival in patients with advanced pancreatic NET
9 February 2011 | By Novartis
NEJM published a study that shows Afinitor® tablets plus BSC more than doubled PFS...
List view / Grid view
9 February 2011 | By Novartis
NEJM published a study that shows Afinitor® tablets plus BSC more than doubled PFS...
9 February 2011 | By IDEA Pharma
IDEA Pharma is delighted to announce the recent appointment of Michael Morgan-Curran to its ever-increasing ranks...
9 February 2011 | By Boehringer Ingelheim
Announcement covers global technical development and manufacturing for antibody-based therapeutics...
8 February 2011 | By Dahlgren Communications
Hamilton introduces the TADM 96 Multi-Channel Pipetting Head, with aspiration & dispense monitoring technology in every channel...
8 February 2011 | By The Scott Partnership
Molecular Profiles, continues expansion of its manufacturing capabilities with the recent purchase of the Xcelodose 120S system...
8 February 2011 | By Premier Research Group Limited
Premier Research Group Ltd, announces the appointment of Sue Robinson to the position of Director of Patient Recruitment...
8 February 2011 | By Johnson & Johnson
Johnson & Johnson and Crucell N.V. provide further information regarding Johnson & Johnson's proposed acquisition of Crucell...
8 February 2011 | By Kapler Communications
New white paper from Malvern examines benefits of real-time analysis for process development...
7 February 2011 | By AstraZeneca
AstraZeneca today announced that the phase III ENTHUSE Study 15...
7 February 2011 | By AstraZeneca
This study is in addition to the companies’ Phase III RENAISSANCE programme for TC-5214...
4 February 2011 | By AstraZeneca
AstraZeneca announced today that the US FDA has acknowledged receipt of the company’s reply to the Complete Response Letter (CRL) for the ticagrelor New Drug Application (NDA)...
3 February 2011 | By NextPharma Technologies
NextPharma the leading European provider of product development, contract manufacturing and cold chain and logistics outsourcing services to the pharmaceutical and biotech industry, is pleased to announce the appointment of Brigitte Genard as Quality Director at its sterile contract development and manufacturing site in Braine-l’Alleud, Belgium.
3 February 2011 | By Aesica Pharmaceuticals
Following the recent announcement that it has signed contracts ahead of acquiring three manufacturing sites from UCB, Aesica Pharmaceuticals has appointed a team...
3 February 2011 | By PwC
PwC has announced the appointment of Andrew Packman as head of the firm’s UK pharmaceutical and life sciences business...
2 February 2011 | By kdm communications limited
Plans include the generation and analyzing of sequence data, and to provide the samples and to host a new, free public database...